[unable to retrieve full-text content]
Week In Review: MGI Tech Raises $200 Million To Manufacture Genomic Sequencing Machines Seeking AlphaHanX Biopharma, a China oncology company, in-licensed China rights to a Phase III candidate for myelodysplastic syndromes from Onconova in a $51.5 million ...
Read Again https://seekingalpha.com/article/4265107-week-review-mgi-tech-raises-200-million-manufacture-genomic-sequencing-machinesBagikan Berita Ini
0 Response to "Week In Review: MGI Tech Raises $200 Million To Manufacture Genomic Sequencing Machines - Seeking Alpha"
Post a Comment